No Data
Express News | Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Are Analysts Bullish on Viridian Therapeutics, Inc. (VRDN) Right Now?
Ladenburg Thalmann Maintains Viridian Therapeutics(VRDN.US) With Hold Rating
Ladenburg Thalmann analyst Michael Higgins maintains $Viridian Therapeutics(VRDN.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 34.3% and a total average return
A Quick Look at Today's Ratings for Viridian Therapeutics(VRDN.US), With a Forecast Between $30 to $46
On Jun 12, major Wall Street analysts update their ratings for $Viridian Therapeutics(VRDN.US)$, with price targets ranging from $30 to $46.Needham analyst Serge Belanger maintains with a buy rating,
Express News | Wolfe Research Initiates Coverage On Viridian Therapeutics With Outperform Rating
Viridian Therapeutics Price Target Maintained With a $30.00/Share by Needham
Viridian Therapeutics Price Target Maintained With a $30.00/Share by Needham